Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBEE.L Regulatory News (BEE)

  • There is currently no data for BEE

Directorate Change

23 Nov 2018 07:00

Baring Emerging Europe Plc - Directorate Change

Baring Emerging Europe Plc - Directorate Change

PR Newswire

London, November 22

23 November 2018

Baring Emerging Europe PLC (the ā€˜Company’)

Directorate Changes

The Board of Directors of the Company announces that Ivo Coulson has advised that he will resign as a non-executive Director of the Company with effect from 30 November 2018.

The Directors are pleased to further announce the appointment of Christopher Granville as a non-executive Director of the Company. He will join the Board on 30 November 2018.

Formerly a British diplomat in the Political Section of the British Embassy in Moscow, Christopher has a wealth of experience in Emerging Europe. He is currently a Board Director and Managing Director of TS Lombard, an independent investment research provider specialising in emerging markets, that was co-founded by Christopher in 2006. Previously, he spent six years as chief strategist and political analyst at United Financial Group (UFG), a Moscow-based investment bank that was acquired by Deutsche Bank in 2006. Christopher joined UFG from Fleming-UCB, where since 1995 he had held the position of managing director and head of research.

Christopher is a member of the Board of Directors of EOS AB and a member of the Investment Committee of Olma Private Equity Fund.

There are no further disclosures required to be made in accordance with LR 9.6.13R of the Listing Rules of the UK Listing Authority.

The Board would like to thank Ivo for his contribution to the Board.

For further information, please contact the Company Secretary on 01392 477500.

LEI: 213800HLE2UOSVAP2Y69

Date   Source Headline
3rd Jan 20209:11 amPRNNet Asset Value(s)
2nd Jan 20209:24 amPRNNet Asset Value(s)
31st Dec 20199:13 amPRNNet Asset Value(s)
30th Dec 20199:15 amPRNNet Asset Value(s)
27th Dec 20199:09 amPRNNet Asset Value(s)
24th Dec 20199:17 amPRNNet Asset Value(s)
23rd Dec 20199:06 amPRNNet Asset Value(s)
20th Dec 20199:26 amPRNNet Asset Value(s)
19th Dec 20199:15 amPRNNet Asset Value(s)
18th Dec 20199:29 amPRNNet Asset Value(s)
17th Dec 20199:26 amPRNNet Asset Value(s)
16th Dec 20199:31 amPRNNet Asset Value(s)
13th Dec 20199:30 amPRNNet Asset Value(s)
12th Dec 20199:03 amPRNNet Asset Value(s)
11th Dec 20199:04 amPRNNet Asset Value(s)
10th Dec 20199:34 amPRNNet Asset Value(s)
9th Dec 20199:16 amPRNNet Asset Value(s)
6th Dec 20199:05 amPRNNet Asset Value(s)
6th Dec 20197:00 amPRNAnnual Financial Report
5th Dec 20199:15 amPRNNet Asset Value(s)
4th Dec 20195:08 pmPRNPortfolio Update
4th Dec 20199:30 amPRNNet Asset Value(s)
3rd Dec 20199:17 amPRNNet Asset Value(s)
2nd Dec 20199:10 amPRNNet Asset Value(s)
29th Nov 20199:20 amPRNNet Asset Value(s)
28th Nov 20199:25 amPRNNet Asset Value(s)
27th Nov 20199:13 amPRNNet Asset Value(s)
26th Nov 20199:27 amPRNNet Asset Value(s)
25th Nov 20199:30 amPRNNet Asset Value(s)
22nd Nov 20199:12 amPRNNet Asset Value(s)
21st Nov 20199:21 amPRNNet Asset Value(s)
20th Nov 20199:24 amPRNNet Asset Value(s)
19th Nov 20199:25 amPRNNet Asset Value(s)
18th Nov 20199:13 amPRNNet Asset Value(s)
15th Nov 20199:20 amPRNNet Asset Value(s)
14th Nov 20199:25 amPRNNet Asset Value(s)
13th Nov 20199:14 amPRNNet Asset Value(s)
12th Nov 20199:18 amPRNNet Asset Value(s)
11th Nov 20199:13 amPRNNet Asset Value(s)
8th Nov 20199:11 amPRNNet Asset Value(s)
7th Nov 20199:24 amPRNNet Asset Value(s)
6th Nov 20199:26 amPRNNet Asset Value(s)
5th Nov 201911:11 amPRNPortfolio Update
5th Nov 20199:13 amPRNNet Asset Value(s)
4th Nov 20199:21 amPRNNet Asset Value(s)
1st Nov 20191:19 pmPRNTotal Voting Rights and Capital
1st Nov 20199:27 amPRNNet Asset Value(s)
31st Oct 20199:11 amPRNNet Asset Value(s)
30th Oct 20195:47 pmPRNTransaction in Own Shares
30th Oct 20199:01 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.